Trial intelligence / Profile preview

Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes

TCTR20140806001Phase 3Completed

Sponsor
Phramongkutklao Hospital and College of Medicine
Start
Aug 2013
Countries
1
01

Overview

A Phase 3 trial of sulodexide in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis, sponsored by Phramongkutklao Hospital and College of Medicine. Started Aug 2013; status: completed.

02

Drugs

sulodexide
03

Conditions

type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis

Beyond the preview

Go deeper on TCTR20140806001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20140806001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call